BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1540548)

  • 1. Acquired tolerance for minor histocompatibility antigens after HLA identical bone marrow transplantation.
    de Bueger M; Bakker A; Goulmy E
    Int Immunol; 1992 Jan; 4(1):53-7. PubMed ID: 1540548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.
    Irschick EU; Hladik F; Niederwieser D; Nussbaumer W; Holler E; Kaminski E; Huber C
    Blood; 1992 Mar; 79(6):1622-8. PubMed ID: 1547351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
    Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
    Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.
    Marijt WA; Veenhof WF; Brand A; Goulmy E; Fibbe WE; Willemze R; van Rood JJ; Falkenburg JH
    J Exp Med; 1991 Jan; 173(1):101-9. PubMed ID: 1985117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
    J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.
    Marijt WA; Veenhof WF; Goulmy E; Willemze R; van Rood JJ; Falkenburg JH
    Blood; 1993 Dec; 82(12):3778-85. PubMed ID: 8260714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
    de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
    Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
    Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; BĂ©langer R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
    De Bueger M; Bakker A; Van Rood JJ; Goulmy E
    Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.
    Kaminski ER; Hows JM; Bridge J; Davey NJ; Brookes PA; Green JE; Goldman JM; Batchelor JR
    Bone Marrow Transplant; 1991 Jul; 8(1):47-50. PubMed ID: 1912955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
    Warren EH; Greenberg PD; Riddell SR
    Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells.
    Hoffmann T; Theobald M; Bunjes D; Weiss M; Heimpel H; Heit W
    Bone Marrow Transplant; 1993 Jul; 12(1):1-8. PubMed ID: 8374531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.